AI Drug Discovery: Multi-Agent Models for Rare Cancers
Analyze the role of multi-agent AI and co-scientist architectures, including withZeta.ai, in accelerating rare cancer drug discovery and modern oncology R&D.
Back to Articles
Articles tagged with “oncology-r-d”